Login / Signup

Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial.

Stefano PartelliSara MassironiAlessandro ZerbiPatricia NiccoliWooil KwonLuca LandoniFrancesco PanzutoAles TomazicAlberto BongiovanniGregory KaltsasAlain SauvanetEmilio BertaniVincenzo MazzaferroMartyn CaplinThomas ArmstrongMartin O WeickertJohn RamageEva SegelovGiovanni ButturiniStefan StaettnerMauro CivesAndrea FrillingCarol Anne MoultonJin HeFlorian BoeschAndreas SelberheerOrit TwitoAntonio CastaldiClaudio G De AngelisSébastien GaujouxKatharina HolzerColin H WilsonHussein AlmeamarEmanuel VigiaFrancesca MuffattiMartina LucàAndrea LaniaJacques EwaldHyeong Seok KimRoberto SalviaMaria RinzivilloAlojz SmidAndrea GardiniMarina TsoliOlivia HenticSamuele ColomboDavide CitterioChristos ToumpanakisEmma RamseyHarpal S RandevaRay SrirajaskanthanDaniel CroaghPaolo RegiSilvia GasteigerPietro InvernizziCristina RidolfiMarc GiovanniniJin-Young JangClaudio BassiMassimo Falconi
Published in: The British journal of surgery (2022)
Keyphrases
  • study protocol
  • phase iii
  • late onset
  • clinical trial
  • phase ii
  • amyotrophic lateral sclerosis
  • open label
  • early onset